Previous 10 | Next 10 |
Rockwell Medical press release (NASDAQ:RMTI): Q1 GAAP EPS of -$0.84 beats by $0.15. Revenue of $16.12M (+4.2% Y/Y) misses by $1.53M. As of March 31, 2022, cash and cash equivalents and working capital totaled $9.9 million and $5.2 million, respectively. Amended and expanded supply agreement w...
Rockwell Medical Provides First Quarter 2022 Financial and Operational Update PR Newswire - First quarter net sales of $16.1 million , up 4.2% year-over-year - - Submitted Supplemental Data to FDA for IND Application to enable Phase 2 FPC Home Infusion Tria...
ADMP, ALBO, ANY, AREC, ASTS, AXDX, CCSI, OTCQX:CWBHF, CWBR, CYRN, DAC, DADA, DNA, EGLX, FTK, FUV, GAN, GLBE, GNLN, HYRE, INPX, IONQ, IPWR, ISUN, IZEA, KBNT, KULR, MARK, MVST, OTCQB:NEXCF, NU, OTCQX:PLNHF, PPSI, PYR, QIPT, REED, REKR, RGTI, RKLB, RMTI, SHLS, OTCQX:SHWZ, SLGG, SNDL, SPI, SPRO, ...
Rockwell Medical (NASDAQ:RMTI) is scheduled to announce Q4 earnings results on Monday, May 16th, after market close. The consensus EPS Estimate is -$0.99 and the consensus Revenue Estimate is $17.65M (+16.1% Y/Y). For further details see: Rockwell Medical Q4 2021 Earnings Preview
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re starting off the final day of the workweek with an overview of the biggest pre-market stock movers for Friday! Source: f11photo/Shutterstock.com A statement from Elon Musk, several earnings reports, and...
Rockwell Medical (NASDAQ:RMTI) shares fell ~16% after the biopharmaceutical company announced a 1-for-11 reverse split of its issued and outstanding common stock, effective May 13, 2022. As a result, every 11 shares of the company's common stock issued and outstanding will be automa...
Rockwell Medical Submits Supplemental Data to FDA for IND Application for Phase 2 FPC Home Infusion Trial PR Newswire WIXOM, Mich. , May 12, 2022 /PRNewswire/ -- Rockwell Medical , Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transfor...
Rockwell Medical Announces 1-for-11 Reverse Stock Split PR Newswire WIXOM, Mich. , May 12, 2022 /PRNewswire/ -- Rockwell Medical , Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia managemen...
Rockwell Medical, Inc. to Report First Quarter 2022 Financial and Operating Results on May 16, 2022 PR Newswire WIXOM, Mich. , May 11, 2022 /PRNewswire/ -- Rockwell Medical , Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming t...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...